FLOTEK INDUSTRIES INC/CN/ FTK

Healthcare SIC 2890 - Miscellaneous Chemical Products NYSE

Flotek strives to be the collaborative partner of choice for solutions that reduce the environmental impact of energy on air, water, land and people. An advanced technology-driven, chemical and data analytics company, Flotek seeks to provide unique and innovative solutions to its customers in both the domestic and international energy markets. The Company is committed to delivering products and services that endeavor to maximize customer returns by leveraging chemistry as the common value creation platform.

The Company's Chemistry Technologies ("CT") segment designs, develops, manufactures, packages, distributes and markets optimized chemistry solutions that we believe help customers improve their return on invested capital, lower operational costs and realize tangible environmental benefits aimed at enhancing the profitability of hydrocarbon producers.

Last close 23.54 2026-09-04
Market cap $852.6M 2026-06-30 share count
52-week range 10.95 - 39.67

Valuation FY2025 figures against the last close

P/S3.6x
P/E28.0x
P/FCF118.4x
EV/EBITDA35.4x
Dividend yield
Diluted EPS0.84

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $237.3M$187.0M$188.1M$136.1M$39.6M$53.1M$119.4M$177.8M$243.1M$188.2M
Cost of revenue $177.4M$147.6M$163.8M$142.8M$40.0M$81.8M$215.1M$170.3M
Gross profit $59.8M$39.4M$24.3M-$6.7M$3.3M-$28.7M$28.0M$90.7M
R&D $1.8M$1.7M$2.5M$4.4M$5.5M$7.2M$8.9M$10.4M$13.1M$9.3M
SG&A $28.0M$24.7M$27.8M$27.1M$20.2M$22.8M$28.0M$31.5M$41.5M$43.7M
Total operating expenses $36.6M$27.2M$1.0M$28.7M$34.7M$115.0M$194.9M$247.6M$253.4M$205.2M
Operating income $23.2M$12.2M$23.2M-$35.4M-$31.5M-$143.6M-$75.5M-$69.8M-$10.3M-$17.0M
Interest expense $3.9M$1.1M$2.9M$7.1M$78.0K$60.0K$2.0M$2.9M$2.2M$2.0M
Pre-tax income $19.7M$11.1M$24.9M-$42.3M-$30.6M-$142.6M-$75.8M-$80.7M-$11.4M-$6.7M
Income tax $10.9M$649.0K$149.0K$22.0K$40.0K$6.2M$262.0K$7.2M$6.1M$2.2M
Net income $30.5M$10.5M$24.7M-$42.3M-$30.5M-$136.4M-$33.9M-$70.3M-$27.4M-$49.1M
EPS, basic 0.900.361.00-3.41-0.42-2.00-0.55-1.21-0.47-0.88
EPS, diluted 0.840.34-0.10-3.41-0.42-2.00-0.57-1.21-0.47-0.88
Shares, diluted (wtd. avg.) $36.2M$30.9M$28.4M$12.4M$73.4M$68.3M$58.8M$58.0M$57.6M$56.1M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $5.7M$4.4M$5.9M$12.3M$11.5M$38.7M$100.6M$3.0M$4.6M$4.8M
Receivables $19.1M$12.0M$11.8M$15.6M$37.0M$34.9M$47.2M
Inventory $10.6M$13.3M$12.8M$15.7M$9.5M$11.8M$23.2M$27.3M$32.5M$58.3M
Total current assets $110.8M$96.5M$76.4M$80.1M$42.6M$66.5M$153.9M$194.8M$137.9M$188.6M
Property, plant and equipment $39.8M$45.5M$52.8M$74.7M
Goodwill $0$8.1M$0$0$37.2M$56.7M
Other intangibles $20.3M$26.8M$22.0M$50.4M
Total assets $220.0M$170.8M$157.5M$164.8M$50.2M$86.2M$230.6M$285.9M$329.9M$383.2M
Accounts payable $48.3M$38.1M$31.7M$33.4M$7.6M$5.8M$16.2M$15.0M$10.4M$30.0M
Short-term debt $1.4M$4.0M$0$49.7M$27.9M$40.6M
Total current liabilities $61.6M$50.4M$47.8M$151.4M$18.8M$28.9M$41.3M$84.3M$64.6M$87.7M
Long-term debt $40.0M$0$60.0K$2.7M$3.4M$1.6M$0$0$7.8M
Total liabilities $107.0M$56.9M$55.6M$162.2M$30.1M$39.0M$58.6M$84.3M$64.6M$95.5M
Retained earnings -$285.8M-$316.3M-$326.8M-$351.5M-$309.2M-$278.7M-$142.2M-$107.6M-$37.2M-$9.8M
Total equity $113.1M$113.9M$102.0M$2.6M$20.2M$47.2M$172.0M$202.0M$265.3M$287.7M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $7.2M$3.4M-$11.3M-$44.6M-$25.8M-$47.8M-$4.5M-$20.8M$12.3M$1.2M
Depreciation and amortisation $1.8M$891.0K$734.0K$734.0K$1.0M$2.5M$6.5M$9.2M$9.8M$8.2M
Stock-based compensation $2.3M$1.4M-$254.0K$3.3M$3.8M$3.0M$4.2M$7.0M$10.6M$11.4M
Capital expenditure $421.0K$39.0K$1.4M$2.4M$3.6M$4.2M$13.1M
Investing cash flow -$2.0M-$1.8M-$1.0M$5.3M$112.0K-$17.7M$152.7M-$2.1M$14.5M-$21.4M
Financing cash flow -$3.7M-$3.1M$5.9M$38.3M-$372.0K$3.7M-$50.0M$21.5M-$27.3M$22.9M
Buybacks $0$0$5.2M$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000928054-26-000020.

Others in SIC 2890

TickerCompanyMarket capP/ERevenue growth
ESI Element Solutions Inc $8.77B 45.6x 3.8%
CBT CABOT CORP $4.21B 13.5x -7.0%
WDFC WD 40 CO $2.79B 31.0x 5.0%
ASPI ASP Isotopes Inc. $643.9M 475.5%
OEC Orion S.A. $344.2M -3.8%
ARQ Arq, Inc. $100.4M 10.4%
FSI FLEXIBLE SOLUTIONS INTERNATIONAL INC $73.6M 96.0x 0.7%
ZTEK Zentek Ltd.